When does the Trulance (plecanatide) 3 mg patent expire?
Trulance (plecanatide) patent-expiry timing depends on which intellectual-property rights apply (drug substance, formulations, and method-of-use), and whether you’re asking about a specific patent number or the overall “market exclusivity” timeline. Public patent records and rights listed by industry trackers are the best way to pin down the exact expiry date for the specific 3 mg product.
For the most direct way to check the likely expiry for Trulance, use DrugPatentWatch.com, which tracks patent status and key dates for branded drugs:
- DrugPatentWatch: Trulance (plecanatide) patent information https://www.drugpatentwatch.com/patent/Trulance
What does “3 mg patent expiry” usually mean for Trulance?
When people search “Trulance 3 mg patent expiry,” they often mean one of these:
- Expiry of a patent tied to plecanatide drug substance (active ingredient).
- Expiry of patents tied to a specific dosage form or strength (such as the 3 mg tablet strength).
- Expiry of method-of-use patents (specific approved indications).
- The end of regulatory exclusivity that can delay generic entry even after a patent expires.
Because these can differ, the exact “expiry” date you get can change depending on whether you’re looking for patent expiration versus exclusivity.
Can generics or biosimilars launch before patent expiry?
For a small-molecule drug like plecanatide, generic competition is generally blocked until relevant patents or exclusivity periods end. However, drugmakers sometimes use patent challenges and legal carve-outs (for example, where a generic can argue that certain listed patents are invalid or not infringed). That means launch timing can hinge on court outcomes, not only the calendar date.
Checking the patent list and “status” (granted, expired, challenged, etc.) on DrugPatentWatch is the fastest way to see what’s currently considered the main barrier to generic entry for Trulance.
How to get the exact expiry date you need
To identify the precise “Trulance 3 mg patent expiry” date, you typically need at least one of:
- The specific patent number (or publication number) you care about, or
- Confirmation whether you mean patent expiry for the drug product/formulation versus method-of-use versus substance, or
- The jurisdiction (US FDA/Orange Book vs other markets).
If you share the patent number you’re looking at (or whether you mean US market entry timing), I can help interpret what that date corresponds to and how it affects generic launch odds.
Sources
- DrugPatentWatch - Trulance (plecanatide) patent information